Most Read News

In adherence to the T+3 timeline, the company is slated to announce the allotment results on November 10.

The IPO includes a fresh issuance of shares worth Rs 400 crore by the company and an offer-for-sale (OFS) of 1.56 crore equity shares by promoters and investors

Even though Info Edge invested Rs 288 crore in the firm, the remaining amount represents the notional loss from the former, higher valuation that the company was able to secure.

Most sectors exhibited positive momentum, with realty, oil & gas, healthcare, and capital goods marking a 1 percent uptick

Here are some of the stocks that may see significant price movement today.

A spokesman for Vedanta's semiconductor and display business stated that talks between the two companies over the display fab are ongoing.

Asian Markets are trading in mixed cues. Chinese Shanghai Composite is trading 0.12% higher.

The company currently operates a renewable energy (RE) portfolio of 8.4 GW, comprising solar, wind, and hybrid capacity

The USFDA closed the inspection of Gland Pharma's Vizag unit, which took place from July 20 to July 28

This approval allows Caplin to market a generic version of Zemuron® Bromide Injection by Organon USA Inc